Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Guocheng Zhong"'
Altered cfDNA fragmentation profile in hypomethylated regions as diagnostic markers in breast cancer
Autor:
Jun Wang, Yanqin Niu, Ming Yang, Lirong Shu, Hongxian Wang, Xiaoqian Wu, Yaqin He, Peng Chen, Guocheng Zhong, Zhixiong Tang, Shasha Zhang, Qianwen Guo, Yun Wang, Li Yu, Deming Gou
Publikováno v:
Epigenetics & Chromatin, Vol 16, Iss 1, Pp 1-13 (2023)
Abstract Background Breast cancer, the most common malignancy in women worldwide, has been proven to have both altered plasma cell-free DNA (cfDNA) methylation and fragmentation profiles. Nevertheless, simultaneously detecting both of them for breast
Externí odkaz:
https://doaj.org/article/fa5b61b7e8794f5eb099a0178933fd6f
Autor:
Guocheng Zhong, Xiaomin Zhang, Zheng Guo, Yujie Gao, Bochen Zhao, Xianhao Liu, Lei Chen, Jingqiao Qiao, Chuan Yu, Lixin Wang, Yisheng Li, Li Yu
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Pancreatic cancer (PC) is one of the most malignant tumors in digestive system due to its highly invasive and metastatic properties. At present, conventional treatment strategies for PC show the limited clinical efficacy. Therefore, novel effective t
Externí odkaz:
https://doaj.org/article/79ed65b2ca964419bb3857f7daccafbd
Publikováno v:
2022 8th International Conference on Systems and Informatics (ICSAI).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8779395f2c32ff789db95a2ed900da1
https://doi.org/10.1109/icsai57119.2022.10005457
https://doi.org/10.1109/icsai57119.2022.10005457
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2022 (2022)
BioMed Research International, Vol 2022 (2022)
Immunotherapy has been widely used in the treatment of lung cancer, and one of the most effective biomarkers for the prognosis of immunotherapy currently is tumor mutation burden (TMB). Although whole-exome sequencing (WES) could be utilized to asses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::004e1ab30392f9ff2ee626f53a739542
https://pubmed.ncbi.nlm.nih.gov/35097114
https://pubmed.ncbi.nlm.nih.gov/35097114
Autor:
Guocheng Zhong, Weiqiang Zhao, Yisheng Li, Guangyi Jin, Wei Zeng, Changhua Yu, Ji Zhou, Li Yu
Publikováno v:
Journal of Cancer. 13(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e0951d1d7fc6f13827925e22644cfd0
https://pubmed.ncbi.nlm.nih.gov/35281868
https://pubmed.ncbi.nlm.nih.gov/35281868
Autor:
Jun Wang, Ming Yang, Mingyang Su, Lirong Shu, Hongxian Wang, Xiaoqian Wu, Guocheng Zhong, Zhixiong Tang, Peng Chen, Shasha Zhang, Yun Wang, Li Yu, Deming Gou
Backgroud: Breast cancer, the most common malignancy in women, has been proved to have both altered plasma cell-free DNA (cfDNA) methylation and fragmentation profiles, nevertheless, simultaneously detecting both of them for breast cancer diagnosis h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56c75dacb1679e2fc9dd2d76cd84db52
https://doi.org/10.21203/rs.3.rs-490423/v1
https://doi.org/10.21203/rs.3.rs-490423/v1
Autor:
Deming Gou, Peng Chen, Hongxian Wang, Lirong Shu, Shasha Zhang, Li Yu, Mingyang Su, Ming Yang, Jun Wang, Xiaoqian Wu, Guocheng Zhong, Yun Wang, Zhixiong Tang
Background Breast cancer, the most common malignancy in women, has been proved to have both altered plasma cell-free DNA (cfDNA) methylation and fragmentation profile, nevertheless, simultaneously detecting both of them for breast cancer diagnosis ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69af7e378b5b4d96bd344b4d0bb8a38f
https://doi.org/10.21203/rs.3.rs-403375/v1
https://doi.org/10.21203/rs.3.rs-403375/v1
Background Immunotherapy has been widely used in the treatment of lung cancer, and one of the most effective biomarker for the prognosis of immunotherapy currently is tumor mutation burden (TMB). Although whole-exome sequencing (WES) could be utilize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e3b4ff749a4fa4121194341529ead7a
https://doi.org/10.21203/rs.3.rs-45668/v1
https://doi.org/10.21203/rs.3.rs-45668/v1
Publikováno v:
International Journal of Medical Sciences
Background: Acute myeloid leukemia (AML) is a malignant hematological disease with high refractory rate. Immune escape of AML cells is one of the underlying mechanisms mediating the relapse of the cancers. Various immunotherapies based on the 'patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edfd7422e4c07e32e7dd22f748c6be3c
https://pubmed.ncbi.nlm.nih.gov/32922200
https://pubmed.ncbi.nlm.nih.gov/32922200
Publikováno v:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
BACKGROUND Circular RNA UBE2D2 (circ_UBE2D2) has been found to be involved in the progression of breast cancer. Exosomes are critical mediators of intercellular communication, however, the function of exosomal circ_UBE2D2 in breast cancer remains vag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b1f58f6b856a02a6e91cf30519f6206
https://doi.org/10.12659/msm.922253
https://doi.org/10.12659/msm.922253